Tocilizumab for refractory morphea in adults: A case series.

Lonowski, Sarah; Goldman, Nathaniel; Kassamali, Bina; Shahriari, Neda; LaChance, Avery; Vleugels, Ruth Ann

Lonowski, Sarah; Goldman, Nathaniel; Kassamali, Bina; Shahriari, Neda; LaChance, Avery; Vleugels, Ruth Ann.

Afiliação

Lonowski S; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
Goldman N; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
Kassamali B; New York Medical College, School of Medicine, Valhalla, New York.
Shahriari N; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
LaChance A; Harvard Medical School, School of Medicine, Boston, Massachusetts.
Vleugels RA; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.

JAAD Case Rep ; 30: 27-29, 2022 Dec.

Article em En | MEDLINE | ID: mdl-36353292

Palavras-chave

CR, complete response; IL-6, interleukin-6; connective tissue disease; immunomodulatory therapy; interleukin-6; localized scleroderma; morphea; tocilizumab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JAAD Case Rep Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JAAD Case Rep Ano de publicação: 2022 Tipo de documento: Article